JP2023532223A5 - - Google Patents
Info
- Publication number
- JP2023532223A5 JP2023532223A5 JP2022577794A JP2022577794A JP2023532223A5 JP 2023532223 A5 JP2023532223 A5 JP 2023532223A5 JP 2022577794 A JP2022577794 A JP 2022577794A JP 2022577794 A JP2022577794 A JP 2022577794A JP 2023532223 A5 JP2023532223 A5 JP 2023532223A5
- Authority
- JP
- Japan
- Prior art keywords
- immediate
- release tablet
- tablet according
- weight
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063041403P | 2020-06-19 | 2020-06-19 | |
| US63/041,403 | 2020-06-19 | ||
| US202063043292P | 2020-06-24 | 2020-06-24 | |
| US63/043,292 | 2020-06-24 | ||
| PCT/EP2021/066386 WO2021255159A1 (en) | 2020-06-19 | 2021-06-17 | Formulation comprising daprodustat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023532223A JP2023532223A (ja) | 2023-07-27 |
| JP2023532223A5 true JP2023532223A5 (https=) | 2024-06-18 |
| JP7797425B2 JP7797425B2 (ja) | 2026-01-13 |
Family
ID=76730508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577794A Active JP7797425B2 (ja) | 2020-06-19 | 2021-06-17 | ダプロデュスタットを含んでなる処方物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230225977A1 (https=) |
| EP (1) | EP4167967A1 (https=) |
| JP (1) | JP7797425B2 (https=) |
| CN (1) | CN115697307A (https=) |
| BR (1) | BR112022024533A2 (https=) |
| CA (1) | CA3180509A1 (https=) |
| WO (1) | WO2021255159A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024521491A (ja) * | 2021-06-18 | 2024-05-31 | グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッド | ダプロデュスタットおよびその前駆体の新規な製造方法 |
| WO2024257063A1 (en) * | 2023-06-16 | 2024-12-19 | Glenmark Life Sciences Limited | Solid dispersion of daprodustat and a process for the preparation thereof |
| WO2025087207A1 (zh) * | 2023-10-24 | 2025-05-01 | 杭州安道药业有限公司 | 含有缺氧诱导因子-脯酰胺羟基化酶抑制剂的长效口服药物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2934B1 (en) | 2006-06-23 | 2015-09-15 | سميث كلاين بيتشام كوربوريشن | Prolyl hydroxylase inhibitors |
| CN101773498B (zh) * | 2009-12-30 | 2012-06-20 | 青岛黄海制药有限责任公司 | 一种含有非布司他的口服缓控释制剂的制备方法 |
| US11324734B2 (en) | 2015-04-01 | 2022-05-10 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
| SI3881833T1 (sl) * | 2015-06-30 | 2024-03-29 | Genentech, Inc., | Tablete s takojšnjim sproščanjem, ki vsebujejo zdravilo in postopek za oblikovanje tablet |
| CA2937365C (en) * | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| PH12018000227A1 (en) * | 2017-09-05 | 2019-03-11 | Frimline Private Ltd | A pharmaceutical composition for improving or preventing progression of chronic kidney disease |
| JP2020533396A (ja) | 2017-09-15 | 2020-11-19 | クリスタル ファーマシューティカル（スーチョウ）カンパニー，リミテッド | Ｇｓｋ１２７８８６３の結晶形及びその製造方法並びに医薬用途 |
| TWI843707B (zh) * | 2017-09-26 | 2024-06-01 | 美商提薩羅有限公司 | 尼拉帕尼（ｎｉｒａｐａｒｉｂ）調配物 |
| CN112955130A (zh) * | 2018-10-30 | 2021-06-11 | 佩洛通治疗公司 | 包含取代茚满的固体分散体和药物组合物及其制备和使用方法 |
| EP3880663A1 (en) * | 2018-11-15 | 2021-09-22 | Teva Pharmaceuticals International GmbH | Solid state forms of daprodustat and process for preparation thereof |
-
2021
- 2021-06-17 WO PCT/EP2021/066386 patent/WO2021255159A1/en not_active Ceased
- 2021-06-17 CA CA3180509A patent/CA3180509A1/en active Pending
- 2021-06-17 CN CN202180043608.0A patent/CN115697307A/zh active Pending
- 2021-06-17 EP EP21736531.1A patent/EP4167967A1/en active Pending
- 2021-06-17 JP JP2022577794A patent/JP7797425B2/ja active Active
- 2021-06-17 US US18/010,245 patent/US20230225977A1/en active Pending
- 2021-06-17 BR BR112022024533A patent/BR112022024533A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5798269B2 (ja) | 薬物高含量錠剤 | |
| JP2023532223A5 (https=) | ||
| KR101667762B1 (ko) | 엔타카폰 또는 이의 염의 서방형 약학 조성물 | |
| JP2021512117A5 (https=) | ||
| TWI724993B (zh) | Ｃ-ｍｅｔ抑制劑的錠劑配方 | |
| JP5183470B2 (ja) | レベチラセタムを含む薬剤組成物及びその調製方法 | |
| JP6122098B2 (ja) | オルメサルタンメドキソミルとロスバスタチンまたはその塩とを含む医薬組成物 | |
| JP2007091758A5 (https=) | ||
| FI3804716T3 (fi) | Farmaseuttinen yhdistelmä, koostumus ja yhdistelmävalmiste, joka käsittää glukokinaasin aktivaattorin ja sglt-2:n estäjän ja niiden valmistusmenetelmiä ja käyttöjä | |
| JP2015506377A5 (https=) | ||
| TWI848241B (zh) | １－（３－氰基－１－異丙基－吲哚－５－基）吡唑－４－羧酸結晶之製備方法及包含彼之醫藥組成物 | |
| JP2019523258A (ja) | エソメプラゾール、又は薬学的に許容可能なその塩を含むｐＨ依存性薬物放出特性が改善した剤形 | |
| JP2003535895A5 (https=) | ||
| JP7797425B2 (ja) | ダプロデュスタットを含んでなる処方物 | |
| KR20180135020A (ko) | 니코틴아미드의 경구 약제학적 조성물 | |
| WO2019142207A1 (en) | Pharmaceutical compositions comprising ibrutinib | |
| JP2023548855A5 (https=) | ||
| WO2018211336A2 (en) | Solid dosage form containing sorafenib tosylate | |
| EP4268806A1 (en) | A tablet comprising sacubitril and valsartan processed with dry granulation | |
| JP2025508402A5 (https=) | ||
| WO2013169218A1 (en) | Pharmaceutical compositions of s-etodolac | |
| CN105232551A (zh) | 一种缬沙坦/苯磺酸氨氯地平复方制剂及其制备方法 | |
| RU2247561C1 (ru) | Комбинированная фармацевтическая композиция с противотуберкулёзным действием | |
| KR102330953B1 (ko) | 소듐-1-[6-(모르폴린-4-일)피리미딘-4-일]-4-(1h-1,2,3-트리아졸-1-일)-1h-피라졸-5-올레이트를 함유하는 제약 투여 형태 | |
| WO2010070611A1 (en) | Atazanavir formulations |